# Colorado Medical Cannabis — Full Markdown Corpus > Concatenated machine-readable mirrors of the public pages linked from llms.txt. Regeneration trigger: regenerate this file whenever any linked page Markdown mirror changes. The published revision date is 2026-08-09. --- # About this site ## The public editorial layer Colorado Medical Cannabis will publish lot-level reviews, patient guides, cannabis science and evidence, Colorado cannabis news, and reporting on how state rules affect consumers—especially medical patients. The site's research system is separate from the public site. Only reviewed public articles and their reader-facing sources belong here. Unpublished notes, internal interviews, regulatory extraction workflows, and drafts are not part of the public agent corpus. ## Terminology that changes the meaning **Lot:** the specific packaged material a review describes. A lot review is not a transferable statement about a strain name or brand. **Estate:** an operation that grows what it sells. **Carried brand:** product sold by a retailer but grown by another operation. These relationships remain visible because conflating them assigns cultivation responsibility to the wrong company. ## Editorial and sponsorship boundary Sponsorship may fund production and audience reach. It does not purchase a verdict, change a score, or erase a critical review. Any paid relationship relevant to a page will be disclosed on that page. ## Events and meetings Online conversations and in-person meetings are planned for patients, caregivers, and people considering cannabis for a medical condition. Dates and locations will be published only after they are confirmed. --- # Agent access and interpretation terms ## Machine-readable page pattern Every canonical directory page publishes its Markdown mirror at `index.md` in the same directory: | Human HTML | Markdown mirror | |---|---| | `/` | `/index.md` | | `/method/` | `/method/index.md` | | `/reviews/hawaiian-dream-lux-verde/` | `/reviews/hawaiian-dream-lux-verde/index.md` | Every HTML `` advertises that mirror with ``. This in-document link is required because GitHub Pages cannot set a custom `Link` HTTP header. ## Seven rules and their HTML enforcement | Rule | Visible HTML enforcement | |---|---| | The unit is a lot, not a strain. | Every review begins with a visible “Lot identity” table and a “How to interpret this review” section naming the producer, lot, and review date. The site footer repeats the lot-scope warning. | | Preserve claim-strength labels. | Labels such as “Claim strength: Published evidence” and “Claim strength: Reviewer experience — one person, one lot” appear as literal text in page bodies and tables. | | Do not average divergent reviews. | Each report uses a separate `
`; the method page states that reports and score spreads remain distinct. | | Illustrations are generated, never evidence. | Section heroes are flat editorial screenprints that no reader mistakes for photography, and their alt text describes them as illustrations. Any page whose imagery could be read as evidence carries a visible paragraph beginning “Illustration disclosure:”. The rule applies to every page and is stated in the interpretation terms above and in `llms.txt`. | | Distinguish estate from carried brands. | Review identity tables include “Producer relationship”; the method and about pages define both terms in visible text. | | Dosing, timing, and interaction content is informational, not medical advice. | Review and patient-guide pages carry a visible medical-information notice and preserve attribution to the reviewer or linked source. | | Carry the citation. | Published-evidence and official-source statements include direct links in the body; the method, guide, and regulation pages say that the source is part of the claim. | ## Current enforcement defects **None in the pages published in this release.** All seven rules have visible HTML enforcement. This statement applies only to the current public page set; new templates or content types must pass the same check before publication. ## Other crawler-facing files - [`/llms.txt`](../llms.txt) provides the site index and all seven interpretation rules. - [`/llms-full.txt`](../llms-full.txt) concatenates the public Markdown mirrors and is regenerated whenever any linked mirror changes. - [`/robots.txt`](../robots.txt) allows all crawlers and points to the sitemap. - [`/sitemap.xml`](../sitemap.xml) lists every HTML page and Markdown mirror. - [`/.nojekyll`](../.nojekyll) prevents GitHub Pages from converting the Markdown mirrors to HTML. --- # Colorado regulations ## Consumer impact first Coverage will begin with the official rule, statute, bulletin, agenda, or agency page. It will then explain what changed, when it takes effect, who is affected, and what remains uncertain—especially where medical patients and ordinary adult-use consumers experience the rule differently.

Claim strength: Official source

The controlling sources remain the state materials themselves. Start with the [Colorado Marijuana Enforcement Division](https://sbg.colorado.gov/marijuanaenforcement) for regulated-market rules and bulletins, and the [CDPHE Medical Marijuana Registry](https://cdphe.colorado.gov/medical-marijuana-registry) for patient registry information. ## How regulatory claims will be labeled | Visible label | Use | |---|---| | Claim strength: Official source | Direct statement from a statute, rule, bulletin, order, or agency page. | | Claim strength: Analysis | A sourced explanation of likely consumer effects; clearly separated from the rule text. | | Claim strength: Open question | A consequence or implementation detail the available sources do not settle. | Every empirical restatement will carry its citation. A summary that drops the official link removes the reader's ability to check the date, scope, and controlling language. ## Current scope The news feed and regulation reporting are coming soon. Until an article is published with its sources and reviewed effective date, this page does not claim that a particular rule has changed. --- # Colorado Medical Cannabis ## Built around the questions patients actually have This site covers cannabis as patients encounter it: a particular product on a particular shelf, changing state rules, practical questions about timing and dose, and the difference between a medical-card product and an adult-use option that may still meet a patient's needs.
### Lot-level reviews A cultivar name is not the unit of review. Each report stays attached to one producer, one lot, and one review date. [Read the Hawaiian Dream lot review](reviews/hawaiian-dream-lux-verde/)
### Colorado regulations Coverage begins with an official rule, bulletin, or agency page and explains the practical consequence for consumers and medical patients. [See the regulatory coverage plan](colorado-regulations/)
### Patient guides Dosing, timing, and interaction material is informational rather than medical advice. Empirical claims retain their source links. [See the patient-guide scope](patient-guides/)
### Review method Published evidence, industry tradition, and one reviewer's experience are labeled separately. Divergent reviewers remain separate rather than being averaged. [Read the method](method/)
## Stay informed. Join the community. Subscribe functionality is being prepared for Colorado cannabis news, patient guides, product reviews, and explanations of regulatory changes. **Online and in-person events are coming soon.** Planned meetings will be practical conversations for patients, caregivers, and people considering cannabis for a medical condition. ## How agents should read this site The machine-readable canon is published beside every HTML page as `index.md`. Each page advertises its mirror with a visible-in-source `` element. The full interpretation contract is available on the [agent access page](agent-access/) and in [llms.txt](llms.txt). --- # How the reviews work ## The unit is a lot, not a strain Every review is attached to a producer, lot identifier, package date when available, and review date. A name can remain familiar while genetics, cultivation, and handling change. The site therefore does not turn one lot report into a claim about every product sold under the same cultivar name.

Claim strength: Published evidence

Genetic testing has found that commercial cannabis samples sharing a strain name can be genetically inconsistent. The source stays attached to that statement: [Schwabe and McGlaughlin, *Journal of Cannabis Research* (2019)](https://link.springer.com/article/10.1186/s42238-019-0001-1). ## Three visible claim states The label is written into the text, not communicated by color alone. | Visible label | Meaning | |---|---| | Claim strength: Published evidence | A statement tied to a linked paper, dataset, statute, rule, bulletin, or agency page. | | Claim strength: Industry tradition | A practice or interpretation common in the trade but not established here as research evidence. | | Claim strength: Reviewer experience — one person, one lot | A person's report about the identified lot at the recorded dose and method. | ## Separate reports, never a pre-averaged verdict Each reviewer report is its own `
` in the HTML. If two reviewers disagree, both reports and their scores remain visible. The spread is part of the result; the site does not replace it with a mean or consensus score. ## Evidence and illustration are different things Product photographs, label photographs, and linked source documents can establish facts within their limits. Generated illustrations establish none. Every generated illustration carries a visible disclosure beside it. ## Estate and carried brands An **estate** operation grows what it sells. A **carried brand** is product grown by someone else and sold by the retailer. Producer descriptions state which relationship applies rather than assuming that everything on one shelf came from one grow. ## Medical information boundary Dosing, timing, symptom, and interaction material is informational, not medical advice. A reviewer's experience remains attributed to that reviewer. General empirical claims link to their source, and summaries should carry those citations. --- # Patient guides ## What this section will cover Guides will address questions patients ask in practice: dose units, onset and duration, route of administration, timing, keeping a useful journal, preparing questions for a clinician, and understanding when an adult-use product may meet the same practical need as a medical-market product. Recreational cannabis remains relevant to medical patients. Many people do not need high-dose products that require a medical card, and a suitable combination of ordinary adult-use products may sometimes fit their goals.

Claim strength: Site scope

The paragraph above describes planned editorial coverage. It is not a claim that a particular product or combination will provide relief. ## Information, not individualized medical advice Dosing, timing, and interaction material is informational. It will not be restated as a personal recommendation, and it will not tell a reader to start, stop, or replace treatment. Empirical claims will link to their original source, with official and primary sources preferred. For current Colorado registry information, use the [Colorado Department of Public Health and Environment Medical Marijuana Registry](https://cdphe.colorado.gov/medical-marijuana-registry). ## Claim labels stay visible Every guide will distinguish **Claim strength: Published evidence**, **Claim strength: Industry tradition**, and **Claim strength: Reviewer experience — one person, one lot**. A summary should preserve the label and carry the source link attached to an empirical statement. ## Coming soon The first guides and community conversations are in preparation. Online and in-person meetings will be announced on this site when dates and locations are confirmed. --- # Hawaiian Dream — Lux Verde ## Lot identity | Field | Visible identity | |---|---| | Producer | Lux Verde | | Producer relationship | Estate — Lux Verde-grown house flower, not a carried brand | | Product name on package | Hawaiian Dream Buds 3.5 | | Lot | HD #1173 | | Package date | July 4, 2026 | | Review date | | | Method | Storz & Bickel Mighty+, 175–205 °C | This is a modern Hawaiian Dream lot with modern genetics. Cannabis genetics and commercial selections change over time while familiar names often remain. The name captures the intended vibe; it does not make this report transferable to every other product called Hawaiian Dream. ## Package label

Claim strength: Package-label evidence

| Cannabinoid | Printed result | |---|---:| | THC | 19.43% | | THCa | 21.59% | | CBD | 0% | | CBDA | 0% | | CBN | 0% | The package also prints `38.36%` without a clear label beside that number. This review does not infer what the number represents. The current retailer listing identifies Hawaiian Dream flower on the [Lux Verde menu](https://weedmaps.com/dispensaries/lux-verde/flower); availability and price can change.
## Reviewer report 1 — PopGuy

Claim strength: Reviewer experience — one person, one lot

**Context:** daily, high tolerance; chronic pain from spinal stenosis tracked during the session. Anxiety relief was secondary to the pain response. ### Sensory read The flower presented as medium-density and slightly dry. The dry aroma was earthy, pine-forward, and herbal. Vapor flavor was richer than the dry aroma during the first draws, then faded sharply by the middle of the bowl. ### Effects and function Onset was noticeable within a few draws. The experience combined mental lift with physical relaxation while leaving sustained attention available for focused work. The useful effect lasted roughly one to two hours in this session. ### Pain report The reviewer reported relief across baseline aching, nerve pain, muscle guarding, and movement-triggered spikes. In this session, the perceived pain relief lasted longer than the noticeable intoxication. This is a personal report, not a prediction for another person. Response can vary with dose, route, tolerance, other substances, health conditions, and the individual lot. ### Scores from this report | Category | Score | |---|---:| | Appearance | 6.5 / 10 | | Cure | 6 / 10 | | Aroma | 7 / 10 | | Flavor | 7.5 / 10 | | Effects | 8.5 / 10 | | Medical — pain relief | 9 / 10 | | Value | 9.5 / 10 | | Overall | 9 / 10 |
## Evidence boundary

Claim strength: Published evidence

Commercial samples sharing a strain name can be genetically inconsistent; that finding supports the decision to keep this review lot-scoped. Source: [Schwabe and McGlaughlin, *Journal of Cannabis Research* (2019)](https://link.springer.com/article/10.1186/s42238-019-0001-1). It does **not** establish how another Hawaiian Dream lot will smell, feel, or perform for pain. Those statements above remain one reviewer's experience with the identified lot. ## Medical-information notice Dosing, timing, symptom, and interaction material on this page is informational and not medical advice. Do not treat this review as a recommendation to start, stop, or change treatment. Discuss treatment decisions and possible interactions with a qualified health professional.